With low dose starting at 1,290 per month, analysts are expecting a two-fold jump in the sale of GLP-1 units over the next three months due to the steep price cuts.

Indian drugmakers seized on the patent expiry for Novo Nordisk A/S's blockbuster weight-loss and diabetes medication to roll out cut-price generic versions in a nation with the third-largest ...

Speaking of gestures, Windows 11’s touch gestures are objectively worse than they were in the past. On Windows 10, swiping in ...

The Artemis II rocket and spacecraft completed the 4-mile trek to the launch pad at Kennedy Space Center on Friday morning, ...

Glenmark Pharmaceuticals has announced the launch of GLIPIQ (semaglutide) in India for the management of Type 2 Diabetes Mellitus (T2DM), positioning it as a more affordable GLP-1 therapy aimed at ...

Market experts say patent expiry of semaglutide could create an incremental revenue opportunity of over Rs 5,000 crore for ...

XPPen, a global leader in digital art innovation, today unveiled its new flagship drawing display, the Artist Pro 27 (Gen 2). Combining professional-grade color performance with advanced X-Touch ...

XPPen Artist Pro 27 (Gen 2) offers high end specs for less.

Natco Pharma will launch its Semaglutide injection (multi dose vials) in the domestic market on Saturday. It will be available tomorrow, day 1 of patent expiry, the Hyderabad-based generic drugmaker ...

Dynabook Americas, Inc., the gold standard for long-lasting, professional-grade laptops, today announced the new Portégé(R) X45W, ...

The Galaxy S26 Ultra impresses with sharp cameras, smart AI features, and a classic design, making it easy to recommend to ...

The Acer Swift X 14 AI delivers high-end performance, a premium display, and an incredible trackpad. But the rest of the machine doesn't feel quite as premium.